Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)
Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)
Recruiting · NCT07670858 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC) | nodular basal cell carcinoma | Recruiting | Phase 1 | 2026-06-29 | NCT07670858 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Feldan Therapeutics | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Equity Medical | New York | United States | 8 |
| Equity Medical | Bowling Green | United States | 7 |
| FNQH Cairns Skin Cancer Clinic | Westcourt | Australia | 1 |
| Innovate Clinical Research | Waitara | Australia | 4 |
| Novatrials | Charlestown | Australia | 15 |
| Scientia Clinical Research | Randwick | Australia | 20 |
| Translational Research Institute | Woolloongabba | Australia | 1 |
| Veracity Clinical Research | Woolloongabba | Australia | 4 |
| Woden Dermatology | Phillip | Australia | 1 |